NCT03832556 (MON-IRM) is a NA clinical trial of CT scan in Neurogenic Myositis Ossificans, sponsored by Assistance Publique - Hôpitaux de Paris.

Who is sponsoring NCT03832556?

NCT03832556 is sponsored by Assistance Publique - Hôpitaux de Paris.

What drugs are being tested in NCT03832556?

Interventions in NCT03832556: CT scan, MRI examination.

What condition does NCT03832556 study?

NCT03832556 studies Neurogenic Myositis Ossificans, Neurogenic Para-osteo-arthritis.

Is NCT03832556 still recruiting?

NCT03832556 is currently completed. Last updated 16 March 2023.

Last reviewed 2023-03-16 · How we verify

NCT03832556: MON-IRM

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison Between CT and MRI in Preoperative Evaluation of Neurogenic Myositis Ossificans or Neurogenic Para-osteo-arthritis

Completed NA Last updated 16 March 2023

What this trial tests

NA trial testing CT scan in Neurogenic Myositis Ossificans in 23 participants. Completed in 7 February 2023.

Timeline

30 April 2019

Primary endpoint
7 February 2023

7 February 2023

Quick facts

Lead sponsor	Assistance Publique - Hôpitaux de Paris
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	23
Start date	30 April 2019
Primary completion	7 February 2023
Estimated completion	7 February 2023
Sites	1 location across France

Drugs / interventions tested

CT scan — full drug profile →
MRI examination

Conditions studied

Neurogenic Myositis Ossificans — all drugs for Neurogenic Myositis Ossificans →
Neurogenic Para-osteo-arthritis — all drugs for Neurogenic Para-osteo-arthritis →

Sponsor

Assistance Publique - Hôpitaux de Paris — full company profile →

Who can join

18 and older, any sex, with Neurogenic Myositis Ossificans or Neurogenic Para-osteo-arthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The principal objective of the study is to compare between CT and MRI diagnostic performance (sensibility and specificity) in the preoperative assessment of neurogenic para-osteo-arthritis. The second objectives of the study are: * besides the diagnostic performance (sensibility and specificity), to evaluate the imaging par MRI in visual and descriptive manner heterotopic ossification and connection with vascular and nervous structures. * to study the concordance (two by two) of results of preoperative obtained by MRI and by CT and operative reports. * to study the characteristics of patients with discordant findings (two by two) by MRI, CT scan and operative report.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Comparison of magnetic resonance imaging and computed tomography for bone assessment of neurogenic heterotopic ossification of the hip: a preliminary study.
Amar R, Thiry T, Salga M, Safa D, et al · · 2021 · cited 11× · PMID 34930354 · DOI 10.1186/s13018-021-02869-6

Verify or expand the search:

Other trials of CT scan

Trials testing the same drug.

NCT07433309 — CT Body Composition as Predictor of Exercise Therapy Outcome in Peripheral Arterial Disease · not yet recruiting
NCT07475260 — SVF-Treo Study: Influence of Cardiac and Respiratory Pulsatility Deformation · not yet recruiting
NCT07389889 — Percutaneous Robotic Navigation Microwave Ablation Versus CT-guided Microwave Ablation in the Treatment of Pulmonary Nod · NA · not yet recruiting
NCT07187791 — CT KUB in Renal Cysts · not yet recruiting
NCT07120529 — Minimally Invasive Surgery Versus Open Radical Hysterectomy in Presumably Early Stage Cervical Cancer: a Retrospective M · recruiting

Other Assistance Publique - Hôpitaux de Paris trials

Trials by the same sponsor.

NCT07443436 — Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants · Phase 2 · not yet recruiting
NCT07499492 — Red Blood Cell Transfusion to Optimize Extubation · NA · not yet recruiting
NCT07379918 — Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer · recruiting
NCT07473869 — Smartphone Application for Automated Measurement of Capillary Refill Time (CRT) · not yet recruiting
NCT07505394 — Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03832556 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assistance Publique - Hôpitaux de Paris
Last refreshed: 16 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03832556.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing